First Allied Advisory Services Inc. lessened its holdings in shares of CVS Health Corp (NYSE:CVS) by 13.6% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 30,629 shares of the pharmacy operator’s stock after selling 4,841 shares during the period. First Allied Advisory Services Inc.’s holdings in CVS Health were worth $2,460,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of CVS. FMR LLC raised its position in shares of CVS Health by 22.0% during the 2nd quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock worth $2,425,920,000 after acquiring an additional 5,446,930 shares in the last quarter. Boston Partners raised its position in shares of CVS Health by 69.1% during the 2nd quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock worth $519,711,000 after acquiring an additional 2,638,888 shares in the last quarter. Parametric Portfolio Associates LLC raised its position in shares of CVS Health by 71.5% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,949,854 shares of the pharmacy operator’s stock worth $317,805,000 after acquiring an additional 1,647,168 shares in the last quarter. Prudential Financial Inc. raised its position in shares of CVS Health by 61.8% during the 2nd quarter. Prudential Financial Inc. now owns 2,946,531 shares of the pharmacy operator’s stock worth $237,078,000 after acquiring an additional 1,125,400 shares in the last quarter. Finally, Nordea Investment Management AB raised its position in shares of CVS Health by 8.4% during the 2nd quarter. Nordea Investment Management AB now owns 14,154,922 shares of the pharmacy operator’s stock worth $1,138,905,000 after acquiring an additional 1,100,373 shares in the last quarter. 82.24% of the stock is currently owned by institutional investors and hedge funds.
In other CVS Health news, EVP Thomas M. Moriarty sold 20,547 shares of CVS Health stock in a transaction that occurred on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total value of $1,667,799.99. Following the transaction, the executive vice president now directly owns 43,178 shares in the company, valued at approximately $3,504,758.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Thomas M. Moriarty sold 90,267 shares of CVS Health stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $79.61, for a total value of $7,186,155.87. Following the completion of the transaction, the executive vice president now owns 70,102 shares in the company, valued at $5,580,820.22. The disclosure for this sale can be found here. Insiders sold a total of 714,125 shares of company stock worth $58,119,381 over the last quarter. Company insiders own 0.61% of the company’s stock.
Several equities research analysts have recently weighed in on the company. Citigroup cut their target price on CVS Health from $88.00 to $87.00 and set a “neutral” rating on the stock in a research report on Thursday, August 17th. Royal Bank Of Canada initiated coverage on CVS Health in a research note on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price target on the stock. Jefferies Group raised their price target on CVS Health from $82.00 to $86.00 and gave the stock a “hold” rating in a research note on Friday, September 15th. Wolfe Research downgraded CVS Health from an “outperform” rating to a “market perform” rating and dropped their price target for the stock from $89.00 to $82.00 in a research note on Monday, August 14th. Finally, Mizuho set a $90.00 price target on CVS Health and gave the stock a “buy” rating in a research note on Tuesday, October 24th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $86.35.
CVS Health Corp (CVS) opened at $73.09 on Friday. CVS Health Corp has a 12 month low of $66.45 and a 12 month high of $84.72. The firm has a market capitalization of $74,039.58, a P/E ratio of 12.80, a price-to-earnings-growth ratio of 1.37 and a beta of 0.89. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67.
CVS Health (NYSE:CVS) last announced its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.01. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The company had revenue of $46.18 billion for the quarter, compared to the consensus estimate of $46.17 billion. During the same period last year, the business posted $1.64 EPS. The company’s revenue was up 3.5% on a year-over-year basis. equities research analysts predict that CVS Health Corp will post 5.9 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “CVS Health Corp (CVS) Shares Sold by First Allied Advisory Services Inc.” was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://ledgergazette.com/2017/12/10/cvs-health-corp-cvs-shares-sold-by-first-allied-advisory-services-inc.html.
CVS Health Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.